Related Experiment Video
Updated: Aug 24, 2026

A Protocol for Multiple Gene Knockout in Mouse Small Intestinal Organoids Using a CRISPR-concatemer
Published on: July 12, 2017
RARgamma acts as a tumor suppressor in mouse keratinocytes
Chang Feng Chen1, Philippe Goyette, David Lohnes
1Division of Experimental Medicine, McGill University, Quebec, Canada.
Abstract:
All-trans retinoic acid (RA), the principle biologically active form of vitamin A, is essential for many developmental process as well as homeostasis in the adult. Many lines of evidence also suggest that RA, acting through the RA receptors (RARs), can also suppress growth of tumors of diverse origin. To assess directly the role of the RARs in a model of epidermal tumorigenesis, we investigated the incidence of tumor formation using keratinocytes lacking specific RAR types. Our data suggest that loss of RARgamma, but not RARalpha, predisposed keratinocytes to v-Ha-Ras-induced squamous cell carcinoma. We also found that ablation of RARgamma, but not RARalpha, abolished RA-induced cell cycle arrest and apoptosis in these keratinocytes. Reconstitution of receptor expression into RAR-null cells restored sensitivity to RA, and reversed the tumorigenic potential of receptor-deficient keratinocytes. These data strongly support a tumor suppressor effect for the RARs, in particular endogenous RARgamma, in murine keratinocytes.
Insights
All-trans retinoic acid (RA) receptors, particularly RARgamma, act as tumor suppressors. Loss of RARgamma in keratinocytes promotes squamous cell carcinoma, while its presence inhibits tumor development.
Area of Science:
- Dermatology
- Molecular Biology
- Oncology
Background:
- All-trans retinoic acid (RA), the active form of vitamin A, is crucial for development and adult homeostasis.
- Evidence suggests RA, via retinoic acid receptors (RARs), can inhibit tumor growth.
Purpose of the Study:
- To investigate the direct role of RARs in epidermal tumorigenesis.
- To assess the specific functions of RARalpha and RARgamma in keratinocytes during tumor development.
Main Methods:
- Utilized keratinocytes genetically modified to lack specific RAR types (RARalpha or RARgamma).
- Induced squamous cell carcinoma using v-Ha-Ras.
- Assessed RA-induced effects on cell cycle arrest and apoptosis.
- Reconstituted RAR expression in null cells to confirm receptor function.
Main Results:
- Loss of RARgamma, but not RARalpha, predisposed keratinocytes to v-Ha-Ras-induced squamous cell carcinoma.
- Ablation of RARgamma, but not RARalpha, abolished RA-induced cell cycle arrest and apoptosis.
- Restoring RAR expression in null cells reversed the tumorigenic potential and restored RA sensitivity.
Conclusions:
- Endogenous RARgamma plays a significant role as a tumor suppressor in murine keratinocytes.
- RARgamma mediates RA's effects on cell cycle arrest and apoptosis, crucial for preventing epidermal tumors.
Related Concept Videos
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Abnormal Proliferation
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Negative Regulator Molecules
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...

